3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
385
Specimen Handling
371
Magnetic Resonance Spectroscopy
325
Radiotherapy
306
Biopsy
269
Cisplatin
257
Carboplatin
253
Paclitaxel
235
Doxorubicin
226
Fluorouracil
200
Etoposide
197
Vincristine
182
Bevacizumab
180
Filgrastim
170
Gemcitabine
163
Leucovorin
149
Cytarabine
144
aldesleukin
140
Taxes
127
Docetaxel
122
Oxaliplatin
113
Chemotherapy, Adjuvant
113
fludarabine phosphate
111
Rituximab
107
Methotrexate
107
Radiation
106
Bortezomib
105
Prednisone
102
Irinotecan
100
Dexamethasone
100
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Interventional
×
Tomography, Spiral Computed
×
Clear all
NCT00047385
2014-05-20
NLST
National Cancer Institute (NCI)
Phase 3
Completed
53,454 enrolled
15 charts